Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen. [electronic resource]
Producer: 20140612Description: 2902-11 p. digitalISSN:- 1600-6143
- Adult
- Allografts
- Anti-Inflammatory Agents -- administration & dosage
- Calcineurin Inhibitors
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Graft Rejection -- diagnosis
- Graft Survival -- drug effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Kidney Failure, Chronic -- complications
- Kidney Function Tests
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Postoperative Complications
- Prednisone -- administration & dosage
- Prognosis
- Prospective Studies
- Sirolimus -- therapeutic use
- Survival Rate
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Tacrolimus -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.